CompletedNCT01701258
Early-Life Stress and Brain Responses in Women With Depression
About this title
Read the official source — NCT01701258Medication studyAges 20–45United States
Understand this study
Who was this study for?
Listed age limits: 20 years to 45 years.
- Listed locations
- Belmont and 1 more locationSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: August 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 153
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 20 Years to 45 Years
- Official registry ID
- NCT01701258
- Official title
Show the full official title
Early Life Stress and Depression: Molecular and Functional Imaging Approaches
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedBelmont · Boston
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Amisulpride and Placebo.
Who was this study for?
Listed age limits: 20 years to 45 years.
